Donors bet a U.S. firm could transform disease testing in Africa. Then COVID-19 hit

Donor organizations poured millions of dollars into U.S. firm Cepheid’s diagnostic equipment to tackle disease in poor countries. When COVID-19 struck, the system fell apart.